← All drafts
Draft #5967 quality rejected Created May 10, 2026, 02:47:05

Pipeline run for this draft

Generated note

3,636 is the May 1, 2026 count for a combined federal MDL covering several GLP-1 drugs, not Ozempic alone. It includes alleged gastroparesis, other GI injuries and warning claims; the count does not show Ozempic- or gastroparesis-specific totals. Defendants deny them. https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-May-1-2026.pdf https://www.paed.uscourts.gov/mdl/mdl-3094-re-glucagon-peptide-1-receptor-agonists-glp-1-ras-products-liability-litigation-gi

Source post

Ozempic now has 3,636 active lawsuits as of this month. Most of them are for the same thing. stomach paralysis. Nobody told these people their gut was the most important conversation to have before starting. Here's what ozempic actually does in the gut.🧵

May 9, 2026, 20:34:50 Open on X →

Pipeline steps

15 steps
Step #1

generate_note.pre_filter

Success
Started
May 10, 2026, 02:47:05
Finished
May 10, 2026, 02:47:14
Duration
9.13 s

Input snapshot

{
  "post_text": "[Target Post]\nOzempic now has 3,636 active lawsuits as of this month.\n\nMost of them are for the same thing.\nstomach paralysis.\nNobody told these people their gut was the most important conversation to have before starting.\n\nHere's what ozempic actually does in the gut.🧵"
}

Output snapshot

{
  "has_factual_claims": true
}